Effect of temsirolimus versus interferon-α on outcome of patients with advanced renal cell carcinoma of different tumor histologies
✍ Scribed by Janice P. Dutcher; Paul de Souza; David McDermott; Robert A. Figlin; Anna Berkenblit; Alexandra Thiele; Mizue Krygowski; Andrew Strahs; Jay Feingold; Gary Hudes
- Book ID
- 107576808
- Publisher
- Springer US
- Year
- 2009
- Tongue
- English
- Weight
- 253 KB
- Volume
- 26
- Category
- Article
- ISSN
- 1357-0560
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Thirty patients with advanced renal cell carcinoma (RCC), 23 of whom had distant metastases in at least one organ, were entered after nephrectomy into a protocol involving vaccination with Newcastle disease virus (NDV)-modified autologous tumour material, with a subsequent induction week and repetit
## Background: In the tnm classification of renal cell carcinoma released in 1997, t1 tumors were defined as organ-confined tumors 7.0 cm or less in size, and t2 as those larger than 7.0 cm. the consideration of tumor size should be predicated on its prognostic value in predicting survival, because
## Impact of Tumor Size on the Clinical Outcomes of Patients with Robson Stage I Renal Cell Carcinoma I read the report by Kinouchi et al., 1 in which they concluded that the tumor grading of renal cell carcinoma was not predictive of the survival of Robson Stage I patients. This does not mean tha